• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Evaluation of the effectiveness of cervical cancer screening: a case-control study in Miyagi, Japan.

作者信息

Makino H, Sato S, Yajima A, Komatsu S, Fukao A

机构信息

Department of Obstetrics and Gynecology, Tohoku University School of Medicine, Sendai, Japan.

出版信息

Tohoku J Exp Med. 1995 Mar;175(3):171-8. doi: 10.1620/tjem.175.171.

DOI:10.1620/tjem.175.171
PMID:7792786
Abstract

To estimate the effectiveness of screening for invasive cervical cancer, a case-control study was performed in Miyagi, Japan. A total of 198 cases (129 mass screen-detected and 69 outpatient-detected) of invasive cervical cancer were identified between 1984 and 1990. The results of the Papanicolaou smear of these cases were compared to those of 396 age- (+/- 5 years) and area-matched controls. Compared with women who had no prior screening (cases 51.6%, controls 16.2%), women who were screened had an odds ratio (OR) for invasive cervical cancer of 0.14 (95% confidence interval [CI] 0.088-0.230). The OR for the 175 cases of squamous cell carcinoma was 0.13 (95% CI 0.077-0.215), while the OR for the 23 cases of screened women with adenocarcinoma was 0.40 (95% CI 0.091-1.753). The time intervals following the last negative smear were assessed and we found an OR for a one-year interval and a two-year interval of 0.09 (95% CI 0.055-0.163) and 0.17 (95% CI 0.083-0.335), respectively. In conclusion, screening for invasive cervical cancer is not only effective but also the degree of protection is high for one to two years.

摘要

相似文献

1
Evaluation of the effectiveness of cervical cancer screening: a case-control study in Miyagi, Japan.
Tohoku J Exp Med. 1995 Mar;175(3):171-8. doi: 10.1620/tjem.175.171.
2
[Case-control study of the effectiveness of mass screening in reducing invasive cervical cancer].[大规模筛查在降低浸润性宫颈癌方面有效性的病例对照研究]
Nihon Sanka Fujinka Gakkai Zasshi. 1991 Sep;43(9):1226-32.
3
Cervical cancer screening in Japan. A case-control study.
Acta Cytol. 1997 Jul-Aug;41(4):1103-6. doi: 10.1159/000332795.
4
Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.筛查可预防的宫颈癌风险:来自瑞典全国性审计的证据。
J Natl Cancer Inst. 2008 May 7;100(9):622-9. doi: 10.1093/jnci/djn099. Epub 2008 Apr 29.
5
Does screening by "Pap" smears help prevent cervical cancer? A case-control study.
Lancet. 1979 Jul 7;2(8132):1-4. doi: 10.1016/s0140-6736(79)90172-7.
6
A case-control study of the effectiveness of cervical cancer screening in Osaka, Japan.日本大阪宫颈癌筛查效果的病例对照研究。
Jpn J Cancer Res. 1988 Dec;79(12):1269-75. doi: 10.1111/j.1349-7006.1988.tb01555.x.
7
Papanicolaou smear screening interval and risk of cervical cancer.
Obstet Gynecol. 1989 Dec;74(6):838-43.
8
False negative rate in mass screening for cervical cancer.宫颈癌大规模筛查中的假阴性率。
Acta Cytol. 1998 May-Jun;42(3):836-7.
9
Screening interval and risk of invasive squamous cell cervical cancer.宫颈癌浸润性鳞状细胞癌的筛查间隔与风险
Obstet Gynecol. 2003 Jan;101(1):29-37. doi: 10.1016/s0029-7844(02)02454-7.
10
Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence.细胞学筛查对腺癌的保护作用较低,对年轻女性的保护作用持续时间较短:佛罗伦萨一项病例对照研究的结果。
Br J Cancer. 2004 May 4;90(9):1784-6. doi: 10.1038/sj.bjc.6601754.

引用本文的文献

1
Exposure Definition in Case-Control Studies of Cervical Cancer Screening: A Systematic Literature Review.宫颈癌筛查病例对照研究中的暴露定义:系统文献回顾。
Cancer Epidemiol Biomarkers Prev. 2021 Dec;30(12):2154-2166. doi: 10.1158/1055-9965.EPI-21-0376. Epub 2021 Sep 14.
2
The Korean guideline for cervical cancer screening.韩国宫颈癌筛查指南。
J Gynecol Oncol. 2015 Jul;26(3):232-9. doi: 10.3802/jgo.2015.26.3.232.
3
Screening for cervical cancer: a systematic review and meta-analysis.宫颈癌筛查:系统评价和荟萃分析。
Syst Rev. 2013 May 24;2:35. doi: 10.1186/2046-4053-2-35.
4
Endocervical glandular neoplasia associated with lobular endocervical glandular hyperplasia is HPV-independent and correlates with carbonic anhydrase-IX expression: a Gynaecological Oncology Group Study.与小叶型宫颈内膜腺增生相关的宫颈内膜腺肿瘤为 HPV 非依赖性的,并与碳酸酐酶-IX 的表达相关:一项妇科肿瘤学组研究。
Br J Cancer. 2013 Feb 19;108(3):613-20. doi: 10.1038/bjc.2012.578. Epub 2013 Jan 8.
5
Recommendations on screening for cervical cancer.宫颈癌筛查建议。
CMAJ. 2013 Jan 8;185(1):35-45. doi: 10.1503/cmaj.121505. Epub 2013 Jan 7.
6
Carbonic anhydrase IX (CA-IX) and high-risk human papillomavirus (H-HPV) as diagnostic biomarkers of cervical dysplasia/neoplasia in Japanese women with a cytologic diagnosis of atypical glandular cells (AGC): a Gynecologic Oncology Group (GOG) Study.碳酸酐酶 IX(CA-IX)和高危型人乳头瘤病毒(H-HPV)作为细胞学诊断为非典型腺细胞(AGC)的日本女性宫颈发育不良/肿瘤的诊断生物标志物:妇科肿瘤学组(GOG)研究。
Br J Cancer. 2011 Jan 18;104(2):353-60. doi: 10.1038/sj.bjc.6606049. Epub 2010 Dec 14.